Garden State Investment Advisory Services »

Arrowhead Pharmaceuticals shares owned by Garden State Investment Advisory Services

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Garden State Investment Advisory Services from 13F filings

Historical chart of Garden State Investment Advisory Services investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Garden State Investment Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Garden State Investment Advisory Services

Quarter filed Position value Share count Share price at filing
2026-03-31 $218k 3.5k 62.70

More positions owned by Garden State Investment Advisory Services

Invesco Exchange Traded Fd T Large Cap Growth (PWB)
NVIDIA Corporation (NVDA)
Palantir Technologies Cl A (PLTR)
Series Portfolios Tr Equable Shares H (HEDG)
Amazon (AMZN)
T Rowe Price Etf Us Equity Resear (TSPA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Apple (AAPL)
Advanced Micro Devices (AMD)
T Rowe Price Etf Cap Appreciation (TCAF)
Broadcom (AVGO)
J P Morgan Exchange Traded F Equity Premium (JEPI)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)

View all positions for Garden State Investment Advisory Services

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
Vanguard Portfolio Management
FMR
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Fred Alger Management
Invesco
Slate Path Capital
Vestal Point Capital
Arrowstreet Capital, Limited Partnership
Baker Bros. Advisors
Driehaus Capital Management

View all funds holding Arrowhead Pharmaceuticals